TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,115,445
|
3,768,139
|
3,005,004 |
| Earnings before taxes |
470,517
|
1,150,001
|
1,009,526 |
| Total assets |
5,394,988
|
5,147,044
|
4,319,251 |
| Current assets |
1,784,679
|
2,172,128
|
2,905,176 |
| Current liabilities |
3,246,515
|
2,902,142
|
2,589,124 |
| Equity capital |
457,701
|
989,590
|
871,349 |
| - share capital |
63,800
|
64,129
|
58,934 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
8.5%
|
19.2%
|
20.2% |
| Turnover per employee |
8,901
|
10,766
|
8,586 |
| Profit as a percentage of turnover |
15.1%
|
30.5%
|
33.6% |
| Return on assets (ROA) | |||
| Current ratio |
55.0%
|
74.8%
|
112.2% |
| Return on equity (ROE) |
102.8%
|
116.2%
|
115.9% |
| Change turnover |
-633,389
|
498,274
|
1,003,893 |
| Change turnover % |
-17%
|
15%
|
50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.